The call is that falling long rates are repricing everything outside tech right now rather than earnings, and Cramer says growth stocks away from semis are the clean way to play it. He is warning ...

U.S. stocks rally widens as falling oil prices and lower Treasury yields boost sectors beyond technology, lifting healthcare ...

Nordica's Fibroid Care Centre has treated 1,000 women with fibroids and adenomyosis using a non-surgical technology called High-Intensity Focused Ultrasoun ...

Discover how MahaVastu's Industrial Vastu protocol revolutionizes factory productivity. This spatial management framework ...

WT outcomes have improved substantially through progress in molecular diagnosis, chemotherapy, radiotherapy, and surgery. Yet ...

Lyme-Old Lyme High School students plant native shrubs, tend local trails and harvest sweet potatoes through the ECOS Club’s environmental stewardship efforts.

UroGen Pharma stock falls 2.2% to $32.72 today. The first patient begins treatment in a Phase 1 study of UGN-501.

Ractigen Therapeutics, a leading clinical-stage biopharmaceutical company developing innovative small activating RNA (saRNA) ...

First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs. approximately 35% with CCTA alone.

Market is driven by food quality monitoring, environmental sensing, and growing demand for rapid odor detection.

Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid) has been granted an accelerated approval by the FDA as a ...